Eravacycline
Small Molecule
Overview
Eravacycline is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1951095).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Eravacycline expires 19 Oct 2037 and exclusivity 27 Aug 2028. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.